Latest news
AbCellera (NASDAQ:ABCL) Shares Surge Ahead of Monday's ABCL635 Phase 2 Trial Results - TechStock²TechStock² · Sat, 08 Aug 2026 14:45:00 GMTOutcome of 'Zeus' Trial Throws Wrench in Heart Disease Theory - NewserNewser · Sat, 08 Aug 2026 11:30:00 GMTVaxart Inc (VXRT) Advances COVID-19 Trial with Attractive Valuation Metrics - GuruFocusGuruFocus · Sat, 08 Aug 2026 03:40:15 GMTAbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business WireBusiness Wire · Fri, 07 Aug 2026 20:30:00 GMTHealth Canada Issues Guidance for Registration and Results Disclosure of Canadian Clinical Trials - McCarthy TetraultMcCarthy Tetrault · Fri, 07 Aug 2026 14:11:43 GMTBaby Formula Lawsuit Families Score Back-to-Back Court Victories Ahead of August Trial - Drugwatch.comDrugwatch.com · Fri, 07 Aug 2026 13:19:33 GMTFrom Weight Loss to Liver Normalization: A Deep Dive Into the SYNCHRONIZE-1 Trial Results - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 07 Aug 2026 12:25:51 GMTKalshi and Polymarket bets on clinical trials criticized as 'ghastly' - NPRNPR · Fri, 07 Aug 2026 10:00:00 GMT